ANXA1 and inflammatory bowel disease: Raised levels of ANXA1 autoantibodies have also been seen in patients with inflammatory bowel disease [75] and systemic lupus erythematosus (SLE), particularly in lupus nephritis [76, 77, indicating a potential role for ANXA1 on B cells in these diseases.